Home Overview Press Room Blog Publications For Students about us
Search

About the States' Policies & Human Biotechnology


Individual states are filling the regulatory void created by the federal government’s failure to provide comprehensive legislation governing human biotechnologies. This is creating an often inconsistent policy patchwork.

California

State action is evident in a number of areas, including embryonic stem cell, cloning, egg retrieval, and assisted reproduction. More than a dozen states have laws banning reproductive cloning, about half of which also prohibit cloning for stem cell research. Dozens of similar bills are introduced in other states each year.

In response to President Bush’s restrictions on the federal funding of human embryonic stem cell research, several states initiated their own funded research programs. California led the way in 2004 with Proposition 71, which set aside $3 billion of public funds for stem cell research over ten years.



Why is Congress trying to weaken the FDA's oversight of dangerous drugs?by Michael HiltzikLos Angeles TimesMay 19th, 2016With looser standards for drug approval, the "21st Century Cures Act" would grant pharmaceutical companies greater leeway in selling their products.
Should Women Be Able to Abort a Fetus Just Because It’s Female?by Emma GreenThe AtlanticMay 16th, 2016A new wave of state legislation prohibits the termination of a pregnancy based on sex, race, and genetic abnormality.
I Want To Put A Baby In You: The Curious Case Of Louisianaby Ellen TrachmanAbove the LawMay 4th, 2016Instead of reasonable regulation, the pending Louisiana bill transparently limits the types of people who can enter surrogacy arrangements.
Here Are the Medals Given to Eugenically Healthy Humans in the 1920sby Ella MortonAtlas ObscuraApril 26th, 2016People were judged alongside livestock at state fairs in better baby and fitter family contests.
Here’s Why that Race-Sex Abortion Ban Bill is So Discriminatoryby Sital KalantryWomen's eNewsApril 19th, 2016The bill accuses women of racially discriminating against their own fetuses.
Yeast Infection Led to Removal of Transplanted Uterusby Denise GradyThe New York TimesApril 8th, 2016Just two weeks after the first US uterus transplant, the organ had to be removed because a common yeast infection posed life-threatening risks.
Whose Body, Whose Property, What Choice?by Alison Irvine & Katayoun Chamany, Biopolitical Times guest contributorsMarch 21st, 2016A recent panel at The New School brought together speakers on health psychology, queer studies, law, life sciences, and more to discuss bodies purchased for labor and care in assisted reproduction.
Texas Woman Is the First Person to Undergo Optogenetic Therapyby Katherine BourzacMIT Technology ReviewMarch 18th, 2016Beyond the implications for treating blind people, this gene therapy trial is also being watched by the neuroscience community.
Why Surrogacy Laws Must Be Established — the Story of the Ott-Dahlsby Keston Ott-DahlHuffPostMarch 18th, 2016When my partner Andrea became a surrogate for another lesbian couple we had no idea we would end up starting over as new parents.
Jordan Schnitzer Gets a Son—and a Court Battle[cites CGS' Marcy Darnovsky]by Nigel JaquissWillamette WeekMarch 16th, 2016A Portland real estate mogul used science and the law to select the sex of his child born via surrogate. The baby's parentage is now in dispute.
Displaying 1-10 of 437  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760